Large-scale genome-wide association and expression quantitative trait loci studies have identified 27 multiple noncoding variants associated with genetic diseases via affecting gene expression. 28
histone-mark profiles and 108 DNA methylation profiles assessed in 36 cell lines and tissues (see 74
Methods for more details as well as Supplementary Fig. 1 and Supplementary Table 1 ). Networks 75 were trained and tuned for each profile separately, resulting in 2,403 highly accurate models with an 76 average AUROC (Area Under the Receiver Operating Characteristic Curve) of 0.908 and an 77 average AUPRC (Area Under the Precision Recall Curve) of 0.904 ( Supplementary Fig. 2b and 78 Supplementary Table 2 ). Compared to DeepSEA, CARMEN not only covers more than twice as 79 many features ( Supplementary Fig. 2a ) but also shows superior accuracy ( Supplementary Fig. 3 , 80 median AUROC 0.973 vs. 0.935, single-tailed Wilcoxon-test p = 1.747 × 10 -25 ; median AUPRC 81 0.975 vs. 0.357, single-tailed Wilcoxon-test p = 5.256 × 10 -154 ). 82 83 DNA physicochemical properties also affect gene expression through influencing the shape 84 properties of flanking sequences near transcription factor binding sites 21 . We incorporated 13 85 conformational and physicochemical DNA properties 22 To reduce the risk of overfitting and high time costs of model training, we adopted a data-driven 93 feature selection approach before model training. Briefly, we pretrained a multilayer neural network 94 and estimated features contributions by comparing the difference in the activation value of each 95 neuron to its 'reference activation' 25 . Using the distribution of contribution scores from each dataset, 96
we selected the features with absolute contribution scores greater than the threshold (Supplementary 97 variants associated with complex human diseases and traits. However, a gap between the 144 association of a locus and the causal variant still exists because many inherited variants and sentinel 145 variants are in strong linkage disequilibrium regions 3,5,42 . We applied CARMEN on 51,878 reported 146 lead SNPs extracted from the GWAS Catalog (https://www.ebi.ac.uk/gwas/home) and found that 147 variants reported by multiple studies obtained significantly higher CARMEN scores than those that 148
were not (single-tailed Wilcoxon-test p = 4.233 × 10 -39 ), confirming previous observations 27 . 149
150
To pinpoint potential causal variants other than lead SNPs, we ran CARMEN on both the reported 151 lead SNPs and variants with strong LD (r 2 >=0.75) and found that 45.33% of the reported lead 152
SNPs show significantly weaker regulatory potential than nearby variants within the same LD block 153 (r 2 > 0.75). While most of the differences were modest, 6.65% of variants showed differences larger 154 than thirty-fold. ( Supplementary Fig. 8 ) 155 156 For example, several GWA studies report that variant rs1701704 is associated with the 157 susceptibility of type 1 diabetes (p < 5 × 10 -8 ) 43-45 , but CARMEN found that this variant shows only 158 very weak regulatory potential (CARMEN score = 0.0024). Meanwhile, CARMEN pinpointed a 159 nearby variant rs705698 with rather high potential (CARMEN score = 0.4070, Fig. 3a ). While 160 rs705698 has few annotations in the UCSC Genome Browser 46 ( Supplementary Fig. 10a,b ), the 161 variant falls into the first intron of gene RAB5B, which is a candidate gene of type 1 diabetes 44 with 162 strong linkage (r 2 =0.90746), and the annotation module of CARMEN suggests that it is a conserved 163 locus with YY1 changed in the K562, HepG2, GM12892 cell lines, YY2 changed HEK293 cell 164 line, CBX5 and CBX1 changed in the K562 cell line ( Supplementary Fig. 11 ). Independent 165 luciferase assays further confirmed the significant change in report expression for rs705698 but not 166 for rs1701704 ( Fig. 3b and Supplementary Table 11 ). Notably, while CARMEN presents crystal 167 clear contrast on the lead SNP and causal SNP, many state-of-the-art tools missed them ( Fig. 3e and 168 Supplementary Table 9 ). Likewise, variant rs1727313 was reported as an SNP associated with type 169 7 2 diabetes (p = 1 × 10 -8 ) 47 . CARMEN found no regulatory potential for this variant (CARMEN 170 score = 0), but the linkage variant rs146239222 showed high regulatory potential (CARMEN score 171 = 0.1999, Fig. 3c ), which was consistent with our luciferase reporter assay ( Fig. 3d and 172 Supplementary Table 11 ). Interestingly, variant rs146239222 is found in an enhancer region 48,49 173 with high H3K27ac modification, DNase clusters, and multiple transcription factor binding, which 174 is also consistent with the output of the CARMEN annotation module ( Supplementary Fig. 10c,d) , 175
and is associated with the expression of MPHOSPH9 in GTEx (p = 1.34 × 10 -91 , 176 ENSG00000051825.10) 50 . 177 178 179 example, the SIK2-correlated variant rs1784782 shows very weak regulatory potential (CARMEN 185 score = 0.0004), while the linked variant rs59921976 presents rather high potential (CARMEN 186 score = 0.6091). The independent MPRA assay confirmed that the CARMEN-predicted causal 187 variant rs59921976 had significant expression changes, but the reported lead SNP rs1784782 did 188 not 53 , and the validated expression-modulating variant rs59921976 was also missed by ExPecto as a 189 nonsignificant variant. 190
191
We calculated feature importance for all CARMEN-E and CARMEN-F features. Consistent with 192 previous reports 28,54 , evolutionary conservation is found to be important for both modules. 193 Furthermore, transcription factor binding profiles play major roles in the CARMEN-E module, 194 while histone markers are more "important" for CARMEN-F, suggesting different aspects of the 195 two modules model ( Supplementary Fig. 9 , Supplementary Table 4 and Supplementary Table 5 ). 196 197 CARMEN is well tuned for large-scale data, running at ~10,000 variants per hour on a modern 198 Linux server ( Supplementary Fig. 13 ). CARMEN is available as both a webserver and a standalone 199 package at http://carmen.gao-lab.org. Designed as a one-stop portal, the CARMEN Web server 200 supports not only on-the-fly prediction but also a user-friendly interface for visualizing the results 201 ( Supplementary Fig. 12 ). To help identify the functional mechanism of noncoding variants' 202 regulation-modulating effects, the Web server provides statistics and specific information about 203 these features in the "Task Results" box as "show details" to help users understand the prediction 204 results. 205 206
Predict variants' effect with sequence-orientated models 209
The raw data for 1,249 transcription factor (TF) binding profiles, 766 histone markers, 280 DNase I 210 -hypersensitive sites and 108 DNA methylation profiles were downloaded from ENCODE 211 (Supplementary Table 1 ). We filtered the data to ensure quality. For TF data, only those involved in 212 conservative irreproducible discovery rate (IDR) peaks and optimal IDR peaks were included. For 213 the data about histone marker profiles, replicated peak data were included. For DNase I -214 hypersensitive sites, pseudoreplicated IDR peak data were used. All data were in bed format, and 215 the reference genome version was GRCh38. The same features (such as CTCF) from different cell 216 lines and using different experimental treatment methods were considered as different chromatin 217
features. 218
To prepare the input for the model, we took a 200 bp window centered on the ChIP-seq peak or 219 target methylation site from all data. For some features, there were several data files from different 220 labs or experiments, and as a result, these features were merged. The merging standard used was 221 that if two sequences from two data files for the same feature overlapped each other, the sequence 222 with a lower peak value was abandoned. Then, the bed files were converted to FASTA files to 223 obtain sequences from the reference genome. During this process, the reverse complement strands 224 were also converted ( Supplementary Fig. 4 ). 225 For the classification model, positive datasets and control datasets were both needed. For ChIP-seq 226 data, we removed the positive data from the reference genome and then split the rest into 200 bp 227 bins. We randomly selected some bins to make the number of the positive and control dataset equal. 228
For methylation data, if the methylation rate of the target site was higher than 50%, it was 229 considered positive data; if the rate was lower than 50%, it was considered control data; and if the 230 rate was 50%, it was abandoned. Positive data were labeled as "1" and control data as "0". 231
Training and testing sets were split randomly in an 85% to 15% ratio. To obtain a reliable and stable 232 model, five-fold cross-validation was conducted. 233
Structure of the model 234
The classification model was a deep convolutional network ( Supplementary Fig. 5 ). The basic layer 235 types in the model were a convolution layer, a pooling layer and a fully connected layer. The first 236 layer of the model was a 1D-convolutional layer, which was responsible for detecting features along 237 the sequences with the activation function ReLU. This layer had 128 or 256 kernels, and the length 238 of each kernel was 4, 10, 12 or 20. Each kernel could be considered a PWM calculator that moved 239 on the sequence with step one. Formally, 240
where X is the input, i is the index of the output position and k is the index of the kernel. W K is the 241 weight matrix whose shape was M × N, M is the kernel length and N is the channel number of the 242 input. The second layer was a 1D-max-pooling layer with a pooling size of 10 or 20. It was used to 243 take the maximal value from nonoverlapping windows. The function of the max-pooling layer was 244 to reduce the dimensionality of the input data. It was defined as 245
MaxPool
where M is the pooling size. 246
The following layers were the dropout layers and fully connected layers with ReLU as the 247 activation function. The fully connected layer multiplied linear combinations of the input and was 248 defined as: 249
where m is the output channel number and n is the input channel number. The dropout layer was 250 used to reduce overfitting by randomly setting a certain proportion of input units to zero during 251 training. We set m to 512 the drop rate to 0.5. 252
The last layer of the model was a fully connected layer with a sigmoid function as the activation 253 function. The sigmoid function scales the prediction to 0-1 and is defined as 254
Training of the model 255
The loss function of the model was binary cross entropy (BCE). Specifically, 256
where t is the true label and p is the prediction of the model. 257
The optimizer was stochastic gradient descent (SGD), and the learning rate was 0.01. Early stop 258 was used during the training process. 
Feature selection 290
We annotated each variant with each feature, and we used a multilayer perceptron neural network to 291 introduce the complex relationship of different features to improve the flexibility of feature 292 interactions ( Supplementary Fig. 6 ). The first three layers learn the code to represent input features 293 by the hidden units. 294
295
A dense layer with L1 regularization is added behind these layers. We added a λ = 0.0001 296 penalty to the model weight and a λ = 0.001 penalty to the output of this layer to increase the 297 sparsity of features. 298 s = λ λ W ( ) d + b ( ) The last two layers of the model are fully connected layers, one with a ReLU activation function 299 and the other with a sigmoid function. The sigmoid function scales the output ranges from 0 to 1. 300
We label the control variants labels as 0 and the positive variants as 1. To solve the binary 302 classification problem of whether the variant has an effect on modulating expression, we trained the 303 multilayer perceptron neural network using 2,424 features with a step size of 300 and then selected 304 the best model as the basic model to perform feature selection. 305
To learn the important features, we used Deep Learning Important FeaTures (DeepLIFT) 25 to 306 calculate the contribution score of each variants' features by comparing the difference in the 307 activation value of each neuron to its 'reference activation'. Here, we chose "all zeros" as the 308 reference. After that, we calculated the distribution of the contribution score of the input data and 309 selected the features with contribution scores higher than the absolute cutoff. We selected features 310 with contribution scores greater than 0.5 or less than -0.5 in the CARMEN-E module and 311 contribution scores greater than 2 or less than -2 in the CARMEN-F module. With two training 312 datasets, after feature selection, we then trained the Adaboost Decision Tree with 689 features and 313 the Random Forest with 1,190 features. 314
The loss function was binary cross entropy, and we used 'Adadelta' to optimize the models with 315 default parameters. The batch size was 100, and each model was trained with 100 epochs. We 316 utilized the early-stopping method and set the patience to 30 to avoid overfitting. We used Keras 317 version 1.1.0 and Python version 2.7.12 to implement the model, and NVIDIA-SMI, Driver version 318 381.22, with a GTX 1080 Ti to train the model. 319
To analyze the different types of feature importance, scikit-learn 0.19.1 was used to calculate 320 feature importance determined by its contributions to the regulation-modulating variant 321 classification. Then, we calculated the cumulative feature importance for each feature category. 322 323
Model selection 324
To optimize the hyperparameters of the model and select the best model for feature selection, we 325 used hidden units, ranging from 1 to the number of features with a step size depending on the 326 number of features. Random-seed for cross-validation, random-seed for models and five-fold cross-327 validation were used for model training. We then selected the best model after using the AUROC to 328 evaluate the performance of the models. 329 330 7 and Supplementary Table 8 ). In the expression module, the positive dataset was the mutagenesis 334 data of experimental validated variants, because high-quality labeled variants can facilitate the 335 methods to distinguish regulatory variants. Since 2009, the parallel reporter assay has been used to 336 study promoters 57 , and later, this assay was modified to derive several assays, such as the MPRA 337 and STARR-seq. Here, we curated data from 4 papers that applied MPRA to confirm regulatory 338 variants. In the function module, the positive variants were from HGMD professional version 339
with disease-causing variants in regulatory mutations and the control variants from 1000 340
Genomes. When comparing the performance of CARMEN-F with other tools, since we randomly 341 selected the 1000 Genomes variants, it is possible that these data were used in training dataset for 342 other tools, and so we curated another independent pathogenic dataset ( Supplementary Table 7 ). We 343 excluded variants that could not map from the GRCh37 to the GRCh38 versions of the human 344 reference genome. 
Model evaluation and application 356
The model was evaluated with two independent datasets with a large number of variants previously 357 tested by self-transcribing active regulatory region sequencing (STARR-seq) in 2018. The first 358 dataset was curated from a study that systematically identified regulatory variants with cancer risk. 359
In this study, the author identified 1,333 variants in the fragments that regulated gene expression 360 from 10,673 variants. Filtering out the variants' reference or alternative alleles in the fragments that 361 did not have statistical significance (DESeq2 58 p values) and the locus that could not map from 362
GRCh37 to GRCh38, we obtained 6,539 variants. Among these variants, 1,164 variants in 363 fragments that regulated gene expression and 65 variants had different regulatory activities in two 364 alleles. 365
366
We also curated another dataset based on the Biallelic Targeted STARR-seq 59 , which tested 43,500 367 variants and identified 2,720 variants with significant ASEs. For these two unbalanced datasets, we 368 calculated the weighted accuracy and F1 score to evaluate the performance. The thresholds of the 369 tools that we compared can be found in Supplementary Table 10 . 370 371 GWAS Catalog v1.0.2 was downloaded from https://www.ebi.ac.uk/gwas/. We also extracted the 372 strongly linked variants (i.e. r 2 > 0.75) with reported lead SNP based on the haplotypes generated by 373 1000 Genomes phase 3 across five populations (CEU, CHB, PUR, TSI, YRI). Then, CARMEN was 374 applied to these variants to identify the potential causal variants other than the reported lead SNP. 375 376 GTEx v7 multi-tissue variants data were from 377 https://storage.googleapis.com/gtex_analysis_v7/multi_tissue_eqtl_data/GTEx_Analysis_v7.metaso 378 ft.txt.gz. Metasoft extends the random effects (REs) meta-analysis model into the RE2 model 52 , 379 which was used in GTEx v7 to evaluate the SNP effects on gene expression across multiple tissues. 380 Furthermore, we wanted to identify the variants that were labeled by the RE2 model as lead SNPs 381 but not the causal variants for the eGenes. We used CARMEN to predict all the variants except 382 those without GRCh38 loci or conservation scores. For each gene, the lead SNP was the most 383 significant variant with the smallest p value calculated by the RE2 model. We also extracted linkage 384 SNPs with an LD r 2 greater than 0.75 with each lead SNP in the CEU population. The lead SNPs in 385 the GTEx multi-tissue eQTLs were all predicted by CARMEN. If the lead SNPs were predicted to 386 be negative by CARMEN, then we selected variants with LD r 2 greater than 0.75 with the lead 387 SNPs. Moreover, we required the high linage variants were not existed in GTEx multi-tissue 388 eQTLs. Then, we used CARMEN to pinpoint the predicted causal SNPs from the negative lead 389 SNPs in each eGene. 390 391
Luciferase reporter assay 392
For the luciferase reporter assay, HEK293T cells were routinely cultured in DMEM/10% FBS until 393 ready for transfection. Cells were plated in each well of a 6-well plate and transfect the cells at 394 ~70% confluency with PEI and transfected with 1 µg pGL4.23 firefly vectors containing the 395 selected fragments using standard restriction-enzyme cloning and Renilla plasmids as a transfection 396 control in a 1:1 ratio. Twenty-four hours after transfection, cells were washed twice with cold 1× 397 PBS, and firefly and Renilla luciferase activity was measured using the Dual-Luciferase Reporter 398 measurements were performed in triplicate for each condition with three independent experimental 400 replicates. Student's t-test was applied to estimate the statistical significance of the difference in 401 luciferase activity between the two alleles. The performance was evaluated on the testing dataset of the curated MPRA dataset with 738 586 variants (207 positive variants, 531 control variants). The ExPecto predicted scores were calculated 587 as the average absolute score of 208 tissues. c, The ROC curve for the CARMEN-F module. The 588 performance was evaluated on a pathogenic dataset with 2,135 variants ( Supplementary Table 7 ). d, 589
The performance comparison of CARMEN to other tools 26 bubbles colored by F1 score. The 590 thresholds of the different tools were obtained from respective official websites or reference papers 591 ( Supplementary Table 10 ). e, The recall of different tools on the known expression-modulating 592 variants 26 . The X axis indicates the proportion of variants from the significant expression-593 modulating variants that were predicted as positive variants by the different tools. f, Performance 594 comparison on a curated list of experimentally characterized variants validated by various low-595 throughput technologies from the literature ( Supplementary Table 3 ). g, Performance comparison 596 on an independent luciferase validated dataset 60 (Supplementary Table 3 The blue star represents the lead SNP, which has been reported in the GWAS Catalog. The dots 611 represent the variants with an LD r 2 greater than 0.75 (CEU) with the lead SNP. The yellow 612 diamond represents the causal variant with best CARMEN score. b and d, Luciferase report assays 613 well validated the prediction in type 1 diabetes mellitus (b) and type 2 diabetes (d). The results were 614 from more than 8 technical replicates with 3 independent experimental replications. e, Comparing 615 the performances of CARMEN and other tools on the two luciferase assays that validated as the 616 positive variants above. 617 Flanking sequences of 15 bp of SNP rs705698 were used to calculate the mutation score. Features 708 annotated by CARMEN with absolute log fold change larger than 1 were selected. The red block 709 indicates that this mutation will increase the binding of this feature. The blue block indicates that 710 this mutation will decrease the binding of this feature. Mutation scores were scaled in each feature. 711
Supplementary Figures
The top heatmap is the mutation score of sequence with reference allele and the bottom heatmap is 712 the mutation score of sequence with alternative allele. 
